Pharming PHAR
NASDAQ PHAR
$13.40 +0.38 (+2.95%)
As of: Nov 11, 2026 · 12:32 PM EST

Pharming (PHAR) Price to Earnings (2021 - 2026)

Updated

Pharming's (PHAR) Price to Earnings stood at 28.93 in Q3 2026, down 98.9% from 2582.32 a year earlier and down 44.0% from the prior quarter.

Analysis

Pharming (PHAR) Price to Earnings (2021 - 2026) Analysis & Trends

For FY2025, Pharming's Price to Earnings came in at 427.54.

  • Across earlier years, Price to Earnings came in at 25.58 in FY2022 (-29.4%) and 36.26 in FY2021 (+41.0%).
  • The Q3 2026 figure is the lowest quarterly Price to Earnings since Q3 2022.
  • Per Business Quant, the preceding three quarters came in at 51.69 (Q2 2026), 94.12 (Q1 2026) and 427.54 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pharming 927.62 Mn 229.29 Mn 102.20
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 28.93
Jun 30, 2026 51.69
Mar 31, 2026 94.12
Dec 31, 2025 427.54
Sep 30, 2025 2,582.32
Dec 31, 2022 52.84
Sep 30, 2022 15.13
Jun 30, 2022 17.34
Mar 31, 2022 25.43
Dec 31, 2021 20.76
Sep 30, 2021 26.50
Jun 30, 2021 22.55
API Access

Pharming Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PHAR&period=max&api_key=YOUR_API_KEY